In the 90 days prior to the date of this filing, there have been 34 insider transactions from the activities of 7 individual insiders all of which have been purchases and resulted in the acquisition of 4,220,250 company shares. Relative to the preceding 90-day window of time, there were 18 transactions from 2 insiders which resulted in the net acquisition of 792,232 shares.
This is less than the average level of insider transactions in the 150-company Pharmaceuticals peer group over the last 90-day period. Activity in the peer group averaged 35.3 transactions per company, and disposition of 6,980 shares on average.
SEC Story Link http://www.sec.gov/Archives/edgar/data/944809/000120919119034967/xslF345X03/doc4.xml
|Golar LNG's 2019, 2020, and Q2 Earnings Estimates Sc...|
|Q3 Consensus Forecast for Guaranty Federal Bancshare...|
|2019, 2020, and Q2 Earnings Estimates for Franklin F...|
|Goodrich Petroleum's Q2 and 2020 Full Year Earnings ...|
|Keane Group's Consensus Forecasts for Q2, 2019, and ...|